878 related articles for article (PubMed ID: 9112351)
1. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
Miller J; Mendez R; Pirsch JD; Jensik SC
Transplantation; 2000 Mar; 69(5):875-80. PubMed ID: 10755543
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized trial comparing the efficacy of tacrolimus versus cyclosporine in black recipients of primary cadaveric renal transplants.
Raofi V; Holman DM; Coady N; Vazquez E; Dunn TB; Bartholomew AM; Pollak R; Benedetti E
Am J Surg; 1999 Apr; 177(4):299-302. PubMed ID: 10326847
[TBL] [Abstract][Full Text] [Related]
4. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.
Mayer AD; Dmitrewski J; Squifflet JP; Besse T; Grabensee B; Klein B; Eigler FW; Heemann U; Pichlmayr R; Behrend M; Vanrenterghem Y; Donck J; van Hooff J; Christiaans M; Morales JM; Andres A; Johnson RW; Short C; Buchholz B; Rehmert N; Land W; Schleibner S; Forsythe JL; Talbot D; Pohanka E
Transplantation; 1997 Aug; 64(3):436-43. PubMed ID: 9275110
[TBL] [Abstract][Full Text] [Related]
5. Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group.
Neylan JF
Transplantation; 1998 Feb; 65(4):515-23. PubMed ID: 9500626
[TBL] [Abstract][Full Text] [Related]
6. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.
Woodle ES; Thistlethwaite JR; Gordon JH; Laskow D; Deierhoi MH; Burdick J; Pirsch JD; Sollinger H; Vincenti F; Burrows L; Schwartz B; Danovitch GM; Wilkinson AH; Shaffer D; Simpson MA; Freeman RB; Rohrer RJ; Mendez R; Aswad S; Munn SR; Wiesner RH; Delmonico FL; Neylan J; Whelchel J
Transplantation; 1996 Sep; 62(5):594-9. PubMed ID: 8830821
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
Johnson C; Ahsan N; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; van Veldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
Transplantation; 2000 Mar; 69(5):834-41. PubMed ID: 10755536
[TBL] [Abstract][Full Text] [Related]
8. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
9. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
10. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive treatment of primary cadaveric renal transplant patients receiving kidneys from non-heart beating donors.
Ohshima S; Fujita T; Ono Y; Kinukawa T; Katoh N; Matsuura O
Artif Organs; 1996 Oct; 20(10):1130-6. PubMed ID: 8896734
[TBL] [Abstract][Full Text] [Related]
12. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
Tsamandas AC; Pham SM; Seaberg EC; Pappo O; Kormos RL; Kawai A; Griffith BP; Zeevi A; Duquesnoy R; Fung JJ; Starzl TE; Demetris AJ
J Heart Lung Transplant; 1997 Jul; 16(7):723-34. PubMed ID: 9257254
[TBL] [Abstract][Full Text] [Related]
13. An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group.
Laskow DA; Vincenti F; Neylan JF; Mendez R; Matas AJ
Transplantation; 1996 Oct; 62(7):900-5. PubMed ID: 8878381
[TBL] [Abstract][Full Text] [Related]
14. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.
Haas M; Meehan SM; Josephson MA; Wit EJ; Woodle ES; Thistlethwaite JR
Am J Kidney Dis; 1999 Jul; 34(1):69-84. PubMed ID: 10401019
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group.
Solez K; Vincenti F; Filo RS
Transplantation; 1998 Dec; 66(12):1736-40. PubMed ID: 9884269
[TBL] [Abstract][Full Text] [Related]
17. Protocol biopsies in pediatric renal transplant recipients on cyclosporine versus tacrolimus-based immunosuppression.
Aoun B; Decramer S; Vitkevic R; Wannous H; Bandin F; Azema C; Callard P; Brocheriou I; Ulinski T
Pediatr Nephrol; 2013 Mar; 28(3):493-8. PubMed ID: 23111894
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
Sollinger HW
Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial.
Bechstein WO; Malaise J; Saudek F; Land W; Fernandez-Cruz L; Margreiter R; Nakache R; Secchi A; Vanrenterghem Y; Tydén G; Van Ophem D; Berney T; Boucek P; Landgraf R; Kahl A; Squifflet JP;
Transplantation; 2004 Apr; 77(8):1221-8. PubMed ID: 15114089
[TBL] [Abstract][Full Text] [Related]
20. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
Neuhaus P; Blumhardt G; Bechstein WO; Platz KP; Jonas S; Mueller AR; Langrehr JM; Lohmann R; Schattenfroh N; Knoop M
Transplantation; 1995 Jan; 59(1):31-40. PubMed ID: 7530868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
